21 – 28 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2011
-
Mark
Bilirubin-A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy
(
- Contribution to journal › Article
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010
(
- Contribution to journal › Scientific review
- 2010
-
Mark
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-na
- Contribution to journal › Article
-
Mark
Differential Effects of Efavirenz, Lopinavir/r, and Atazanavir/r on the Initial Viral Decay Rate in Treatment Naive HIV-1-Infected Patients
(
- Contribution to journal › Article
- 2009
-
Mark
Treatment of HIV infection: Swedish recommendations 2009
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2007
(
- Contribution to journal › Scientific review
-
Mark
Treatment of chronic hepatitis B infection: An update of Swedish recommendations
(
- Contribution to journal › Scientific review
- 1999
-
Mark
Long-term pattern of HIV-1 RNA load in perinatally infected children
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »